160 related articles for article (PubMed ID: 16326109)
1. An overview of apoptosis and the prevention of colorectal cancer.
Watson AJ
Crit Rev Oncol Hematol; 2006 Feb; 57(2):107-21. PubMed ID: 16326109
[TBL] [Abstract][Full Text] [Related]
2. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
Jalving M; Koornstra JJ; De Jong S; De Vries EG; Kleibeuker JH
Aliment Pharmacol Ther; 2005 Feb; 21(4):321-39. PubMed ID: 15709983
[TBL] [Abstract][Full Text] [Related]
3. Review article: the chemoprevention of colorectal carcinoma.
Gasche C
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():31-5. PubMed ID: 15352891
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer and genetic alterations in the Wnt pathway.
Segditsas S; Tomlinson I
Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colorectal cancer.
Das D; Arber N; Jankowski JA
Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
[TBL] [Abstract][Full Text] [Related]
6. Prospects in NSAID-derived chemoprevention of colorectal cancer.
Chell S; Patsos HA; Qualtrough D; H-Zadeh AM; Hicks DJ; Kaidi A; Witherden IR; Williams AC; Paraskeva C
Biochem Soc Trans; 2005 Aug; 33(Pt 4):667-71. PubMed ID: 16042570
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
Liu HF; Hsiao PW; Chao JI
Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
[TBL] [Abstract][Full Text] [Related]
8. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents.
Greenwald P; Kelloff GJ; Boone CW; McDonald SS
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):691-702. PubMed ID: 8672984
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
Arber N
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and the immune response as targets for the prevention and treatment of colorectal cancer (review).
Sharma RA; Dalgleish AG; Steward WP; O'Byrne KJ
Oncol Rep; 2003; 10(5):1625-31. PubMed ID: 12883750
[TBL] [Abstract][Full Text] [Related]
12. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
13. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
Konturek PC; Kania J; Burnat G; Hahn EG
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB and apoptosis in colorectal tumourigenesis.
Aranha MM; Borralho PM; Ravasco P; Moreira da Silva IB; Correia L; Fernandes A; Camilo ME; Rodrigues CM
Eur J Clin Invest; 2007 May; 37(5):416-24. PubMed ID: 17461988
[TBL] [Abstract][Full Text] [Related]
16. The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis.
Nittka S; Günther J; Ebisch C; Erbersdobler A; Neumaier M
Oncogene; 2004 Dec; 23(58):9306-13. PubMed ID: 15568039
[TBL] [Abstract][Full Text] [Related]
17. Failure of apoptosis and activation on NFkappaB by celecoxib and aspirin in lung cancer cell lines.
Gradilone A; Silvestri I; Scarpa S; Morrone S; Gandini O; Pulcinelli FM; Gianni W; Frati L; Aglianò AM; Gazzaniga P
Oncol Rep; 2007 Apr; 17(4):823-8. PubMed ID: 17342322
[TBL] [Abstract][Full Text] [Related]
18. Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development, and assessment of the risks.
Ahmed FE
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004; 22(2):91-147. PubMed ID: 16291519
[TBL] [Abstract][Full Text] [Related]
19. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction cross-talk during colorectal tumorigenesis.
Liu X; Lazenby AJ; Siegal GP
Adv Anat Pathol; 2006 Sep; 13(5):270-4. PubMed ID: 16998321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
